Compare IQV & PHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | PHG |
|---|---|---|
| Founded | 1982 | 1891 |
| Country | United States | Netherlands |
| Employees | 93000 | 65340 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9B | 26.1B |
| IPO Year | 2013 | N/A |
| Metric | IQV | PHG |
|---|---|---|
| Price | $173.29 | $27.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $230.56 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 920.6K |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.01% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 7.84 | N/A |
| Revenue | ★ $9,739,000,000.00 | N/A |
| Revenue This Year | $6.77 | $2.79 |
| Revenue Next Year | $5.87 | $4.38 |
| P/E Ratio | ★ $22.00 | $28.46 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $134.65 | $21.48 |
| 52 Week High | $247.05 | $33.44 |
| Indicator | IQV | PHG |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 41.50 |
| Support Level | $157.59 | $26.44 |
| Resistance Level | $193.26 | $28.29 |
| Average True Range (ATR) | 5.86 | 0.53 |
| MACD | 1.87 | 0.05 |
| Stochastic Oscillator | 71.27 | 39.66 |
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.